Neodymium Magnet-Guided Removal of Metallic Soft Tissue Foreign Bodies in the Emergency Department

November 3, 2026 updated by: Ziya Uzun, Uludag University

Efficacy and Safety of Neodymium Magnet-Guided Removal of Metallic Foreign Bodies in Soft Tissue in the Emergency Department

The goal of this clinical trial is to learn if a strong magnet (neodymium magnet) can help doctors remove metal objects stuck under the skin in adults. It will also learn about the safety of this method. The main questions it aims to answer are:

  • How often can doctors remove the metal object with the help of the magnet?
  • How long does the procedure take?
  • How often do doctors need to make a cut in the skin, and how long is the cut?
  • What problems do participants have within 15 days after the procedure?
  • How satisfied are participants with the procedure?

Participants will:

  • Have an X-ray to find the metal object
  • Have the metal object removed with the help of the magnet in the emergency department, with or without numbing medicine (local anesthetic)
  • Come back for a wound check 15 days after the procedure

Study Overview

Detailed Description

This prospective, single-center, single-arm study is conducted in the Emergency Department of Bursa Uludag University Faculty of Medicine Hospital. Before the procedure, the location of the foreign body and its distance from the skin surface are measured on X-ray, and the entry site is photographed. Before sterile preparation, the magnetic property of the foreign body is confirmed with the neodymium magnet. After sterile preparation, the foreign body is localized with a sterile-draped neodymium magnet. Local anesthesia is applied if needed. The foreign body is removed through the existing wound or, if there is none, through a skin incision. The site is photographed again after removal. Prophylactic antibiotics are given for contaminated wounds. Participants are re-evaluated at suture removal or 15 days after the procedure.

Study Type

Interventional

Enrollment (Estimated)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Bursa
      • Bursa, Bursa, Turkey (Türkiye), 16059
        • Recruiting
        • Bursa Uludag University Faculty of Medicine Hospital, Emergency Department
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18 years or older
  • Metallic foreign body in the soft tissue detected on plain radiography
  • Foreign body located less than 2 cm from the skin surface
  • Foreign body with magnetic properties that interacts with the magnet
  • Signed written informed consent

Exclusion Criteria:

  • Age under 18 years
  • Foreign body located close to structures such as blood vessels, nerves or joint spaces
  • Deep location requiring surgical removal
  • Inability to cooperate
  • Bleeding or coagulation disorder
  • Refusal to sign informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Neodymium Magnet-Guided Removal

Adults with a magnetic metallic foreign body in the soft tissue. The foreign body is removed with the help of a neodymium magnet in the emergency department, with or without local anesthesia.

After sterile preparation, the foreign body is localized and pulled toward the skin surface with a sterile-draped neodymium (NdFeB) magnet, and removed through the existing wound or a skin incision.

Other Names:
  • Rare earth magnet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Successful removal of the foreign body
Time Frame: During the procedure (Day 0)

Number and percentage of foreign bodies successfully removed with the help of the neodymium magnet.

During the procedure (Day 0)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complete removal per participant
Time Frame: During the procedure (Day 0)

Number and percentage of participants in whom all foreign bodies were successfully removed.

During the procedure (Day 0)
Procedure time
Time Frame: During the procedure (Day 0)

Duration of the foreign body removal procedure, in minutes.

During the procedure (Day 0)
Need for additional incision and its length
Time Frame: During the procedure (Day 0)

Number and percentage of participants who need a new or additional skin incision, and the length of the incision in millimeters, if required.

During the procedure (Day 0)
Volume of local anesthetic
Time Frame: During the procedure (Day 0)

Volume of local anesthetic used during the procedure, in milliliters, in participants who receive local anesthesia.

During the procedure (Day 0)
Complications
Time Frame: 15 days after the procedure

Number and percentage of participants with complications (such as wound infection or bleeding) within 15 days after the procedure.

15 days after the procedure
Patient satisfaction
Time Frame: Immediately after the procedure (Day 0)

Participant satisfaction with the procedure on a 5-point Likert scale (1 = not satisfied at all, 5 = very satisfied). Higher scores mean greater satisfaction.

Immediately after the procedure (Day 0)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ziya Uzun, MD, Uludag University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 9, 2025

Primary Completion (Estimated)

January 5, 2027

Study Completion (Estimated)

January 5, 2027

Study Registration Dates

First Submitted

November 3, 2026

First Submitted That Met QC Criteria

November 3, 2026

First Posted (Actual)

November 9, 2026

Study Record Updates

Last Update Posted (Actual)

November 9, 2026

Last Update Submitted That Met QC Criteria

November 3, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because the informed consent form and ethics approval do not cover sharing of individual-level data with third parties. Aggregated results will be published.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe